Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial - Wikidata - wikimedia - TriplyDB

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

http://www.wikidata.org/entity/Q36624106

about

Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer.Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function Systemic Therapy of Cholangiocarcinoma.Guidelines for chemotherapy of biliary tract and ampullary carcinomas Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: a phase II-study (NCT00356161).Biliary tract cancers: current concepts and controversies.Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009 Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.GUIDELINE FOR THE MANAGEMENT OF BILE DUCT CANCERS BY THE BRAZILIAN GASTROINTESTINAL TUMOR GROUP.Surgery and chemotherapy for intrahepatic cholangiocarcinoma.Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study.Current management of cholangiocarcinoma.

P2860

Q30300756-59D03A45-5E7D-428A-BDC3-EF86BF79EABB Q33372640-AE1C8E29-A275-4F85-8CBF-35EB605D6B9E Q33420378-47C4C8E5-1D8F-4663-9130-C69F378DF483 Q33593207-BE6056B5-CE8E-4B2A-8328-C971E9671492 Q34551877-BE93D824-867A-480E-A220-A992A1CE9FCB Q34588361-98953751-7C2A-4222-B345-D8B24B1FBBC7 Q34911078-8717D135-C9E2-488F-9E44-7D341626C3D4 Q36066076-CAF91460-B2A2-495D-8A6B-8204D6F75CAC Q36614800-64FF8315-ABB9-464D-96DF-361F3DB7AFDE Q37295836-7AAD4BEA-9149-4A2C-9075-2FB3EB93A5AE Q37347327-DA1DE139-DF7C-44A5-8F58-0F3C485A418E Q37817003-FF9FBE0B-1AE6-498C-9690-715C74C529E8 Q38858942-F2F804AE-9521-45BD-899D-63686A763BD8 Q41140456-8582368D-14CF-4B06-85E5-597E7F1B822F Q42693724-B0B13CC4-C4B6-462D-8A31-C4CF589682F4 Q45159737-5860580F-2094-457A-BE94-3681D9798BCE

P2860

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

http://www.wikidata.org/entity/Q36624106

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Oxaliplatin, fluorouracil and ...... : a prospective phase II trial

@ast

Oxaliplatin, fluorouracil and ...... : a prospective phase II trial

@en

type

label

Oxaliplatin, fluorouracil and ...... : a prospective phase II trial

@ast

Oxaliplatin, fluorouracil and ...... : a prospective phase II trial

@en

prefLabel

Oxaliplatin, fluorouracil and ...... : a prospective phase II trial

@ast

Oxaliplatin, fluorouracil and ...... : a prospective phase II trial

@en

P1433

Q36624106-403D5426-1DAB-4EE2-9A1D-8A3FB4140646

P1476

Q36624106-B3CA5C4E-A61A-423A-A459-FB19C4765048

P2093

Q36624106-1F54A340-4011-4B69-BB9C-DEDE89E2A225

Q36624106-3B9FD41C-83D8-40D5-9C0D-A211C3B1259A

Q36624106-5216E5BA-279A-4F0C-B963-E44DD4D50330

Q36624106-8FDDAC07-E47D-4840-AA3A-BA6B2F44F7AA

Q36624106-9346C439-4C7A-471D-B411-2AA91A706106

Q36624106-BD8A7B72-3B83-4D42-B0AE-3C76AF5B94C2

Q36624106-F12C4D6A-C051-435E-85F4-41F4DC5A35E1

P2860

Q36624106-1D2B51E6-ABA5-4ACD-9943-4651E8E3A4FE

Q36624106-3FA12E22-FAA8-4E41-A639-621018BDBB75

Q36624106-428A1884-E6C4-4C78-A1ED-7439DEB4BB7E

Q36624106-4EE8594D-A157-4D93-BF66-937FB780B1D5

Q36624106-96E53758-9001-4D54-9C90-2CBC0EE6CC28

Q36624106-B57A3F4F-3E68-4DC0-8785-6BBFEB83DEED

Q36624106-C0211EF6-A20D-40E6-B61C-FE68120C8C0F

Q36624106-E334C0A9-D506-4A7F-B88D-29619473AD5D

P2888

Q36624106-2BBF8B09-6E8D-4A4E-9D55-2CEFBED00E72

P304

Q36624106-2252FEDC-5233-4B28-BFE6-69A1681E59A4

P31

Q36624106-27113E06-8A61-4B19-83B2-BB41318C8EE5

P356

Q36624106-851A8436-584B-4CF5-BEC7-6D4AB505EAF7

P407

Q36624106-4A132787-4481-4B80-AC53-70EBAA8BF4CA

P433

Q36624106-DBB24650-3C6E-4331-A064-15A2DA7438D0

P478

Q36624106-A4588060-AAB2-48B0-B2D6-527A15F9A737

P577

Q36624106-595745D9-49AC-4FB2-8D39-12B89E90A1B1

P5875

Q36624106-4591263F-6B5A-4BD3-8BB1-E1EB67DBE13A

P6179

Q36624106-8852137E-4817-493D-BB41-9713F4681D59

P698

Q36624106-A608267A-ECC2-464A-9350-9A5F9ED62113

P921

Q36624106-2B030777-8203-432C-BA08-966FC1B7AB11

Q36624106-4286BE50-0ECC-4B96-8B89-68FD7F060FB9

P932

Q36624106-D1E71BD4-70B4-4E25-B7FE-7DB4BE27C623

P356

P1433

British Journal of Cancer

P1476

Oxaliplatin, fluorouracil and ...... : a prospective phase II trial

@en

P2093

A Greschniok

http://www.w3.org/2001/XMLSchema#string

B Klump

http://www.w3.org/2001/XMLSchema#string

H G Hass

http://www.w3.org/2001/XMLSchema#string

H T Arkenau

http://www.w3.org/2001/XMLSchema#string

M Gregor

http://www.w3.org/2001/XMLSchema#string

O Nehls

http://www.w3.org/2001/XMLSchema#string

R Porschen

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.

Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study.

Photodynamic therapy of nonresectable cholangiocarcinoma.

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.

P2888

P304

702-704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6600543

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11157255

http://www.w3.org/2001/XMLSchema#string

P6179

1016551013

http://www.w3.org/2001/XMLSchema#string

P698

12232749

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

2364257

http://www.w3.org/2001/XMLSchema#string